| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Nov 19, 2024 | GeneDx Holdings Corp. | 10% Owner | Sell | 15.0 | -147,141 | -5.13% | ✗ | $10.4M |
| Nov 1, 2024 | Nov 5, 2024 | Renalytix plc | 10% Owner | Buy | 100.0 | +13,366,750 | 61.74% | ✗ | $1.6M |
| Oct 31, 2024 | Nov 4, 2024 | GeneDx Holdings Corp. | 10% Owner | Sell | 15.0 | -865,800 | -23.20% | ✗ | $64.9M |
| Apr 24, 2024 | Apr 26, 2024 | Renalytix plc | 10% Owner | Buy | 100.0 | +9,360,374 | 76.17% | ✗ | $2.3M |
| Jan 31, 2023 | Feb 2, 2023 | GeneDx Holdings Corp. | 10% Owner | Buy | 100.0 | +28,571,428 | 30.20% | ✗ | $10M |
| Apr 29, 2022 | May 5, 2022 | GeneDx Holdings Corp. | 10% Owner | Buy | 97.5 | +6,250,000 | 7.07% | ✗ | $25M |